If you are sourcing pharmaceutical PVP, I recommend starting with the required function rather than choosing a grade by K-value alone. PVP, also called povidone or polyvinylpyrrolidone, is a water-soluble polymer used in pharmaceutical formulations as a binder, solubilizer, film former, stabilizer, and processing aid. The most suitable grade depends on dosage form, target viscosity, process conditions, impurity limits, and the documentation required for your market.
For more information, please visit our website.
In practical terms, lower-K PVP grades are generally considered when lower solution viscosity and easier processing are important, while higher-K grades are considered when stronger film-forming, binding, or viscosity-building performance is needed. Crosslinked PVP, commonly called crospovidone, is a separate insoluble but swellable material used mainly as a tablet disintegrant. I recommend confirming the exact grade, applicable pharmacopoeial requirements, test methods, packaging, and supply conditions before approving a purchase.
I prepared this guide for pharmaceutical manufacturers, formulation scientists, quality teams, purchasing departments, contract manufacturers, and distributors evaluating PVP suppliers. It is also useful for buyers comparing povidone grades for tablets, capsules, liquid products, topical preparations, and other drug-delivery applications. The objective is to connect material selection with formulation performance and procurement risk.
Because PVP performance depends on the formulation and manufacturing process, no single grade is universally best. A technical decision should be based on laboratory evaluation, product specifications, and regulatory requirements. Supplier documentation should support the decision, but it should not replace your own qualification and compatibility work.
Pharmaceutical PVP is a synthetic, water-soluble polymer based on N-vinylpyrrolidone. It is valued for its ability to interact with water and many active pharmaceutical ingredients, while also forming clear films and improving adhesion. Depending on grade and application, it can influence granulation, tablet strength, dissolution behavior, suspension stability, and coating performance.
These functions are not interchangeable. A grade that performs well as a tablet binder may not be the most practical choice for a low-viscosity liquid formulation. I therefore recommend evaluating viscosity, wetting, drying behavior, dissolution, and compatibility together rather than relying on one specification.
Soluble povidone is commonly identified by a K-value, such as K12, K17, K25, K30, K60, or K90. The K-value is associated with polymer characteristics and solution viscosity behavior, but it should not be treated as a direct substitute for a complete viscosity specification. The actual result can also depend on concentration, temperature, test method, molecular-weight distribution, and material history.
| Material option | Typical selection logic | Important checks |
|---|---|---|
| Lower-K povidone | Lower viscosity solutions and applications requiring easier flow or processing | Solution viscosity, binding strength, dissolution, moisture, and compatibility |
| Medium-K povidone, such as K25 or K30 | Common starting point for tablet binding and multifunctional formulation development | Granulation behavior, tablet hardness, disintegration, and API interaction |
| Higher-K povidone | Applications where stronger film formation or higher viscosity may be useful | Mixing, pumping, drying, coating uniformity, and dissolution impact |
| Crospovidone | Tablet and capsule disintegration through swelling and capillary action | Particle size, water uptake, disintegration time, and compression behavior |
The table is a selection framework rather than a substitute for a product specification. Grade availability varies between suppliers and regions, and a supplier may offer different naming conventions or product families. I suggest requesting samples from at least three candidate grades when the formulation is still in the development stage.
In wet granulation, povidone is often dissolved or dispersed in the granulating liquid before being added to the powder blend. It can improve cohesion and reduce friability, but excessive binder or an unsuitable grade may slow disintegration or alter dissolution. Formulators should compare granule size, drying endpoint, tablet tensile strength, friability, disintegration, and dissolution.
PVP may be used to improve powder binding or support the performance of selected solid dosage forms. However, direct compression depends strongly on powder flow, compressibility, lubricant level, particle-size distribution, and equipment settings. I recommend testing PVP within the complete excipient system rather than evaluating it as an isolated ingredient.
Soluble PVP can be considered for selected solutions, suspensions, sprays, gels, and topical systems where film formation, wetting, or stabilization is relevant. The formulation team should check clarity, viscosity, pH compatibility, preservative performance, and API stability. A material that dissolves readily in water may still interact with other excipients or affect the sensory and processing properties of the final product.
PVP can contribute to film formation and may be used in systems designed to improve wetting or dispersion of poorly water-soluble ingredients. Its suitability depends on the coating solvent, drying conditions, target film properties, and the active ingredient. For modified-release or specialized delivery systems, PVP should be evaluated alongside the release-controlling polymers and not selected solely for its water solubility.
Yuking supply professional and honest service.
When I evaluate pharmaceutical PVP, I review identity, appearance, solubility, viscosity or K-value, pH, loss on drying or moisture, residue on ignition, assay-related requirements, and impurity controls where applicable. The exact limits should come from the agreed product specification and the relevant pharmacopoeial or regulatory framework. Buyers should also confirm whether the specification applies to povidone or crospovidone, because these are functionally different materials.
Test conditions matter as much as numerical limits. For example, viscosity should be interpreted together with solution concentration, temperature, spindle or instrument method, and measurement time; a value obtained from a 1% solution is not directly comparable with a result from another concentration. I recommend asking for the certificate of analysis, safety documentation, batch traceability, retest or shelf-life information, and a clearly defined change-notification process.
First, I identify whether the material is required primarily as a binder, solubilizer, film former, stabilizer, or disintegrant. If the purpose is disintegration, I assess crospovidone rather than soluble povidone. If the purpose is binding, I compare at least one suitable low- or medium-K grade with the current formulation benchmark.
Next, I list the required grade, dosage form, target market, packaging, analytical methods, and documentation. The buyer should state whether a compendial grade, customer-specific specification, or additional impurity assessment is needed. This step prevents a purchasing decision based only on price per kilogram.
I recommend evaluating the candidate material in the intended process, including mixing, granulation, drying, compression, coating, or filling. Useful development endpoints may include tablet hardness, friability, disintegration time, dissolution profile, solution viscosity, and appearance. The formulation team should document both the initial result and the acceptable operating range.
Before approval, I check production consistency, batch documentation, packaging integrity, storage guidance, minimum order quantity, lead time, sample availability, and communication speed. Commercial packaging is often offered in units such as 25 kg, but the actual pack size should be confirmed with the supplier. I also ask how the supplier handles raw-material changes, manufacturing-site changes, deviations, and out-of-specification investigations.
One common mistake is assuming that all K30 materials are automatically equivalent. K-value alone does not describe every characteristic that can affect a formulation, including moisture, particle size, residuals, solution behavior, and lot-to-lot consistency. Another mistake is selecting a low-cost material without confirming documentation, traceability, and delivery reliability.
Some buyers also confuse soluble povidone with crospovidone. Soluble PVP is typically considered for binding, film formation, or solubilization, while crospovidone is designed for disintegration and has different physical behavior. Finally, I do not recommend changing PVP grade, supplier, or packaging size without a documented impact assessment and appropriate requalification.
At Yuking, I approach pharmaceutical PVP sourcing as a technical and commercial qualification process. We can help buyers clarify the intended application, compare suitable PVP or crospovidone options, arrange samples where available, and review the documentation required for internal approval. Our support is designed for manufacturers, distributors, and export buyers working in pharmaceutical and related specialty-chemical supply chains.
Because each project has different requirements, I encourage buyers to provide the target grade, application, estimated annual volume, destination market, packaging preference, and required documents in the first inquiry. This allows us to respond with a more relevant proposal instead of offering a generic material. Final suitability remains subject to the buyer’s formulation trials, quality review, and regulatory assessment.
The right pharmaceutical PVP grade is the one that meets the formulation function, test requirements, regulatory expectations, and supply conditions of your project. I recommend starting with a clear application definition, comparing suitable grades under the same test conditions, and confirming the complete quality documentation before commercial approval. This approach is more reliable than choosing only by K-value or purchase price.
For the next step, send Yuking your intended application, preferred PVP grade, estimated quantity, packaging requirement, and destination market. I can then help organize a practical quotation and technical review for your pharmaceutical PVP sourcing project.
The company is the world’s best pharmaceutical pvp supplier. We are your one-stop shop for all needs. Our staff are highly-specialized and will help you find the product you need.